Inpharma Weekly

, Volume 1667, Issue 1, pp 21–21 | Cite as

EXTREME results mean cetuximab use is extended

Media release
  • 4 Downloads

Keywords

Cell Cancer Squamous Cell European Commission Advanced Disease Cetuximab 

Copyright information

© Adis International Ltd 2008

Personalised recommendations